# FDA recall D-1065-2017

> **Cantrell Drug Company** · Class II · drug recall initiated 2017-07-14.

## Product

Glycopyrrolate Injection Solution, 5 mL 1 mg/5 mL (0.2 mg/mL) Single-Dose Syringe, Rx Only, Cantrell Drug Company 7321 Cantrell Rd Little Rock, AR 72207 877-666-5222; NDC 52533-028-15

## Reason for recall

Lack of Sterility Assurance.

## Distribution

Nationwide within the US

## Key facts

- **Recall number:** D-1065-2017
- **Recalling firm:** Cantrell Drug Company
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-07-14
- **Report date:** 2017-08-16
- **Termination date:** 2020-09-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Little Rock, AR, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1065-2017

## Citation

> AI Analytics. FDA recall D-1065-2017. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1065-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*